Clinical Trial Update: A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and tolerability of lucerastat in Fabry disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Lucerastat (lucerastat)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Fabry Disease | Phase 1 | Status: COMPLETED